|Women and Cardiovascular Disease|
Cardiovascular disease is the number one killer of both men and women in the United States. However, cardiovascular disease in men and women isn’t necessarily the same disease process.
|Volume 4, Issue 5||September 2019|
|Implantable Cardioverter Defibrillator Shared Decision-Making Tool|
With the BayCare-wide adoption and institution of this ICD decision tool, heart failure patients in our community will be able to make better informed decisions that they can feel good about.
|Volume 4, Issue 4||July 2019|
|Frailty Assessment in Cardiovascular Patients|
The addition of frailty level to our current clinical predictors of outcomes improves a physician's ability to help patients make an informed, shared decision.
|Volume 4, Issue 3||May 2019|
|Low-Risk TAVR Trials|
Transcatheter Aortic Valve Replacement (TAVR) in patients at low-risk for Surgical Aortic Valve Replacement (SAVR).
|Volume 4, Issue 2||March 2019|
|Type 2 Diabetes Mellitus and Cardiovascular Disease|
Tight glucose control with insulin prevents microvascular complications in patients with type 2 diabetes mellitus (DM), but has not been shown to prevent macrovascular complications or improve cardiovascular mortality.
|Volume 4, Issue 1||January 2019|
|Diabetic Limb Salvage|
The new SVS WIfI classification provides a staging system for the increasing diabetic population with PVD to guide amputation risk and need for revascularization.
|Volume 3, Issue 6||November 2018|
|Catheter Ablation of Ventricular Tachycardia|
Although we divide VT into two different groups (patients with and without structural heart disease), in this discussion we’ll be referring to VT in a patient with structural heart disease.
|Volume 3, Issue 5||September 2018|
|Cardiovascular Screening in Young Athletes|
Pre-participation screening is an integral part of identifying individuals who may be at risk for cardiac problems including sudden cardiac arrest and sudden cardiac death.
|Volume 3, Issue 4||July 2018|
|Chronic Total Occlusions|
CTOs are prevalent in approximately 20 percent of
the patients who undergo cardiac catheterization and can be as high as 50 percent in patients with a previous history of bypass.
|Volume 3, Issue 3||May 2018|
|Adult Congenital Heart Disease|
Regardless of a patient’s CHD complexity, virtually all CHD-related diagnostic or interventional management should be conducted by cardiologists who are specially trained in CHD imaging, CHD catheter intervention and CHD electrophysiology.
|Volume 3, Issue 2||March 2018|
|Cardiac Computed Tomography|
Recent rapid technologic advances have contributed to the widespread clinical use of cardiac computed tomography (CT).
|Volume 3, Issue 1||January 2018|
|LVAD - Mechanical Circulatory Support|
BayCare is investing heavily in both destination LVAD
therapy and ECMO programs.
|Volume 2, Issue 6||November 2017|
|Circulatory Support in the Management of Cardiogenic Shock|
Cardiogenic shock is a life-threatening medical condition resulting from an inadequate circulation of blood due to primary failure of the ventricles of the heart to function effectively.
|Volume 2, Issue 5||September 2017|
|Society of Thoracic Surgeons (STS) National Database - Setting the Standard|
The STS database provides a standardized format for data collection and allows comparison of outcomes and elective public reporting for participating heart surgery programs who are willing to share their results with consumers.
|Volume 2, Issue 4||July 2017|
|Benefits of Cardiac Rehabilitation|
Cardiac rehabilitation is a comprehensive secondary prevention program that developed as an important component of care following the hospitalization of patients with cardiovascular disease.
|Volume 2, Issue 3||May 2017|
|Mitral Valve Disease|
Treatment guidelines are evolving to encourage early referral for surgical therapy in severe mitral regurgitation.
|Volume 2, Issue 2||March 2017|
All the exciting potential advances in the field of medicine are very dependent on the conduct of clinical trials.
|Volume 2, Issue 1||January 2017|
|Cardiovascular CME Conferences|
Two events that further the level of cardiovascular knowledge across the BayCare clinical community, broadening the ability to positively impact the lives of our patients.
|Volume 1, Issue 3||November 2016|
|Updates in Arrhythmia|
Performance and quality measures to help identify patients with atrial fibrillation as a way of promoting optimal disease management.
|Volume 1, Issue 2||September 2016|
|Evidenced-Based Diuretic Management of Hospitalized Heart Failure Patients|
Important data has become available on how to more effectively use diuretics to relieve symptoms quickly and durably.
|Volume 1, Issue 1||July 2016|